1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Heart Attack Global Clinical Trials Review, H2, 2014

Heart Attack Global Clinical Trials Review, H2, 2014

  • September 2014
  • -
  • Global Data
  • -
  • 78 pages

Heart Attack Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Heart Attack Global Clinical Trials Review, H2, 2014" provides data on the Heart Attack clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Heart Attack. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Heart Attack. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Heart Attack Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Heart Attack 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Heart Attack to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Heart Attack to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Heart Attack 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Heart Attack Therapeutics Clinical Trials 29
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Takeda Pharmaceutical Company Limited 32
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 32
Sociedade Tecnico-Medicinal, S.A. 33
Clinical Trial Overview of Sociedade Tecnico-Medicinal, S.A. 33
GlaxoSmithKline plc 34
Clinical Trial Overview of GlaxoSmithKline plc 34
Kowa American Corporation 35
Clinical Trial Overview of Kowa American Corporation 35
IPCA Laboratories Limited 36
Clinical Trial Overview of IPCA Laboratories Limited 36
Bayer AG 37
Clinical Trial Overview of Bayer AG 37
AstraZeneca PLC 38
Clinical Trial Overview of AstraZeneca PLC 38
Amgen Inc. 39
Clinical Trial Overview of Amgen Inc. 39
Clinical Trial Overview of Top Institutes / Government 40
University College Cork 40
Clinical Trial Overview of University College Cork 40
Brigham and Women's Hospital 41
Clinical Trial Overview of Brigham and Women's Hospital 41
Sheffield Teaching Hospitals NHS Foundation Trust 42
Clinical Trial Overview of Sheffield Teaching Hospitals NHS Foundation Trust 42
Yale University 43
Clinical Trial Overview of Yale University 43
William Beaumont Hospitals 44
Clinical Trial Overview of William Beaumont Hospitals 44
University of Southern Denmark 45
Clinical Trial Overview of University of Southern Denmark 45
University of Edinburgh 46
Clinical Trial Overview of University of Edinburgh 46
University of Ottawa Heart Institute 47
Clinical Trial Overview of University of Ottawa Heart Institute 47
University of Illinois 48
Clinical Trial Overview of University of Illinois 48
University of Auckland 49
Clinical Trial Overview of University of Auckland 49
Five Key Clinical Profiles 50
Appendix 76
Abbreviations 76
Definitions 76
Research Methodology 77
Secondary Research 77
About GlobalData 78
Contact Us 78
Disclaimer 78
Source 78

List of Tables
Heart Attack Therapeutics, Global, Clinical Trials by Region, 2014* 7
Heart Attack Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Heart Attack Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Heart Attack Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Heart Attack Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Heart Attack Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Heart Attack Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Heart Attack Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Heart Attack to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Heart Attack Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Heart Attack Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Heart Attack to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Heart Attack Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Heart Attack Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Heart Attack Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Heart Attack Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Heart Attack Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Heart Attack Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Heart Attack Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Heart Attack Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Heart Attack Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27
Heart Attack Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Heart Attack Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Heart Attack Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014* 32
Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by Sociedade Tecnico-Medicinal, S.A., 2014* 33
Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 34
Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by Kowa American Corporation, 2014* 35
Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by IPCA Laboratories Limited, 2014* 36
Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 37
Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 38
Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 39
Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by University College Cork, 2014* 40
Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2014* 41
Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by Sheffield Teaching Hospitals NHS Foundation Trust, 2014* 42
Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2014* 43
Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by William Beaumont Hospitals, 2014* 44
Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Southern Denmark, 2014* 45
Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Edinburgh, 2014* 46
Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Ottawa Heart Institute, 2014* 47
Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Illinois, 2014* 48
Heart Attack Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Auckland, 2014* 49

List of Figures
Heart Attack Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Heart Attack Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Heart Attack Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Heart Attack Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Heart Attack Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Heart Attack Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Heart Attack Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Heart Attack Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Heart Attack to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Heart Attack Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Heart Attack Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Heart Attack to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Heart Attack Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Heart Attack Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Heart Attack Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Heart Attack Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Heart Attack Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Heart Attack Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Heart Attack Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Heart Attack Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27
Heart Attack Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Heart Attack Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Heart Attack Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 77

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.